← Leaderboards
Reuben J Shaw
Salk Institute For Biological Studies
$29,207,114
Attributed
$30,775,293
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.7M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$61,634,163 · 15
By mechanism
P30$39,900,765 · 7
R35$10,178,788 · 1
R01$8,715,791 · 3
P01$2,716,015 · 2
F32$118,804 · 1
R13$4,000 · 1
Top collaborators
- Jan Karlseder5 shared
Most similar at Salk Institute For Biological Studies
Same institution · by research overlap
- Anis Contractor$15,866,467
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGrantProgramsPathway InteractionsFundingSignal PathwayMetabolismGrowthSignal TransductionCancer Center Support GrantCancer CenterGeneticPlayMediatingPhosphotransferasesMouse ModelMetabolicCollaborationsIn VivoResource SharingMolecularMemberNutrientAutophagocytosis
Grant awards (72)
Cancer Center Support Grant (CCSG)$3,028,775
P30 · FY2025 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$1,140,000
R35 · FY2025 · CA · contact PI
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma$466,751
P01 · FY2025 · CA · contact PI
Leadership, Planning, and Evaluation (LPE)$252,400
P30 · FY2025 · CA · contact PI
Developmental Funds (DEVFUNDS)$252,400
P30 · FY2025 · CA · contact PI
Administration (ADMIN)$252,400
P30 · FY2025 · CA · contact PI
Pancreatitis-induced initiation of early onset pancreatic cancer$188,541
P30 · FY2025 · CA · contact PI
Cancer Center Support Grant (CCSG)$3,028,775
P30 · FY2024 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$1,140,000
R35 · FY2024 · CA · contact PI
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis$606,831
R01 · FY2024 · CA
Developmental Funds (DEVFUNDS)$579,482
P30 · FY2024 · CA · contact PI
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma$443,412
P01 · FY2024 · CA · contact PI
Administration (ADMIN)$354,588
P30 · FY2024 · CA · contact PI
Leadership, Planning, and Evaluation (LPE)$348,601
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant$3,067,033
P30 · FY2023 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$1,140,720
R35 · FY2023 · CA · contact PI
Developmental Funds$720,836
P30 · FY2023 · CA · contact PI
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis$625,994
R01 · FY2023 · CA
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma$466,752
P01 · FY2023 · CA · contact PI
Cancer Center Administration Core$420,140
P30 · FY2023 · CA · contact PI
Leadership, Planning, and Evaluation$259,428
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant$3,067,033
P30 · FY2022 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$1,140,720
R35 · FY2022 · CA · contact PI
Developmental Funds$720,836
P30 · FY2022 · CA · contact PI
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis$625,994
R01 · FY2022 · CA
Cancer Center Administration Core$420,140
P30 · FY2022 · CA · contact PI
Leadership, Planning, and Evaluation$259,428
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$3,067,033
P30 · FY2021 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$1,164,000
R35 · FY2021 · CA · contact PI
Developmental Funds$720,836
P30 · FY2021 · CA · contact PI
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis$638,770
R01 · FY2021 · CA
Cancer Center Administration Core$420,140
P30 · FY2021 · CA · contact PI
Leadership, Planning, and Evaluation$259,428
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant$3,067,033
P30 · FY2020 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$1,164,000
R35 · FY2020 · CA · contact PI
Developmental Funds$720,838
P30 · FY2020 · CA · contact PI
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis$638,770
R01 · FY2020 · CA
Cancer Center Administration Core$420,140
P30 · FY2020 · CA · contact PI
Leadership, Planning, and Evaluation$259,428
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$3,067,033
P30 · FY2019 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$1,129,078
R35 · FY2019 · CA · contact PI
Developmental Funds$720,838
P30 · FY2019 · CA · contact PI
Cancer Center Administration Core$420,140
P30 · FY2019 · CA · contact PI
Leadership, Planning, and Evaluation$259,428
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$3,092,538
P30 · FY2018 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$1,164,000
R35 · FY2018 · CA · contact PI
Cancer Center Support Grant$3,092,538
P30 · FY2017 · CA · contact PI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer$996,270
R35 · FY2017 · CA · contact PI
AMPK and AMPK-related kinases in lung cancer development and treatment$402,550
R01 · FY2017 · CA · contact PI
Cancer Center Support Grant$3,092,538
P30 · FY2016 · CA · contact PI
AMPK and AMPK-related kinases in lung cancer development and treatment$402,550
R01 · FY2016 · CA · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$270,873
P01 · FY2016 · CA · contact PI
LKB1- AMPK pathway regulation of glucose metabolism and metformin action in liver$465,600
R01 · FY2015 · DK · contact PI
AMPK and AMPK-related kinases in lung cancer development and treatment$402,550
R01 · FY2015 · CA · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$271,271
P01 · FY2015 · CA · contact PI
LKB1- AMPK pathway regulation of glucose metabolism and metformin action in liver$465,600
R01 · FY2014 · DK · contact PI
AMPK and AMPK-related kinases in lung cancer development and treatment$390,474
R01 · FY2014 · CA · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$263,723
P01 · FY2014 · CA · contact PI
LKB1- AMPK pathway regulation of glucose metabolism and metformin action in liver$449,305
R01 · FY2013 · DK · contact PI
AMPK and AMPK-related kinases in lung cancer development and treatment$402,550
R01 · FY2013 · CA · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$254,112
P01 · FY2013 · CA · contact PI
Protein Kinases and Protein Phosphorylation$4,000
R13 · FY2013 · CA · contact PI
LKB1- AMPK pathway regulation of glucose metabolism and metformin action in liver$465,600
R01 · FY2012 · DK · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$279,121
P01 · FY2012 · CA · contact PI
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver$340,280
R01 · FY2011 · DK · contact PI
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver$343,718
R01 · FY2010 · DK · contact PI
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver$347,190
R01 · FY2009 · DK · contact PI
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver$347,190
R01 · FY2008 · DK · contact PI
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver$354,275
R01 · FY2007 · DK · contact PI
FUNCTIONAL ANALYSIS OF THE PEUTZ JEGHERS SYNDROME KINASE$46,192
F32 · FY2002 · CA
FUNCTIONAL ANALYSIS OF THE PEUTZ JEGHERS SYNDROME KINASE$40,196
F32 · FY2001 · CA
FUNCTIONAL ANALYSIS OF THE PEUTZ JEGHERS SYNDROME KINASE$32,416
F32 · FY2000 · CA